Proline residues in the maturation and degradation of peptide hormones and neuropeptides  by Mentlein, Rolf
Volume 234, number 2, 251-256 FEB 06071 July 1988 
Review Letter 
Proline residues in the maturation and degradation of peptide 
hormones and neuropeptides 
Rolf Mentlein 
Anatomisches Institut der Christian-Albrechts Universitiit zu Kiel, OlshausenstraJe 40.2300 Kiel I, FRG 
Received 4 May 1988; revised version received 23 May 1988 
The proteases involved in the maturation of regulatory peptides like those of broader specificity normally fail to cleave 
peptide bonds linked to the cyclic amino acid proline. This generates several mature peptides with N-terminal X-Pro- 
sequences. However, in certain non-mammalian tissues repetitive pre-sequences of this type are removed by specialized 
dipeptidyl (amino)peptidases during maturation. In mammals, proline-specific proteases are not involved in the biosyn- 
thesis of regulatory peptides, but due to their unique specificity they could play an important role in the degradation 
of them. Evidence exists that dipeptidyl (amino)peptidase IV at the cell surface of endothelial cells sequesters circulating 
peptide hormones which arc then susceptible to broader aminopeptidase attack. The cleavage of several neuropeptides 
by prolyl endopeptidase has been demonstrated in vitro, but its role in the brain is questionable since the precise localiza- 
tion of the protease is not clarified. 
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1. INTRODUCTION 
The unique cyclic and imino structure of the 
amino acid proline influences not only the confor- 
mation of peptide chains, but also restricts the at- 
tack of proteases. Peptide bonds involving proline 
residues are often resistant to the action of endo- 
and exopeptidases [l-4], even those with broad 
specificity (table 1). On the other hand, several 
proteases are known which specifically or selective- 
ly attack proline bonds (table 2). This report sum- 
marizes some recent findings about the influence 
of proline residues (i) on the proteolytic processing 
of neuropeptides and peptide hormones from their 
precursors, and (ii) on the final degradation of 
these regulatory peptides. 
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2. DIRECTION OF THE PROTEOLYTIC 
MATURATION OF REGULATORY 
PEPTIDES BY PROLINE RESIDUES 
Regulatory peptides are synthesized as part of 
larger precursors, namely the prepro-peptides. The 
N-terminal pre-sequence is cleaved by a signal pep- 
tidase in the rough endoplasmic reticulum [5-81. 
Further proteolytic maturation occurs in the Golgi 
apparatus and in the secretory vesicles. The key 
proteolytic enzymes for the processing of pro- 
peptides include [7,8] an endopeptidase cleaving at 
paired basic residues, further a carboxypeptidase 
B-like enzyme and/or an aminopeptidase B-like 
enzyme for the removal of C- and N-terminal ex- 
tended basic residues from the fragments. Other 
proteases [7-91 as well as further nonproteolytic 
modifications like glutaminyl cyclisation [lo], 
acetylation, amidation, glycosylation [6-81 may 
also be necessary, depending on the complexity of 
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Table 1 
Peptide bonds stabilized against proteolytic attack by some common proteases by involvement of proline 
residues 
Protease Peptide bonds ( -), normally cleaved if Pro is 
replaced by other amino acids 
Trypsin - (Arg, Lys) - Pro - 
Chymotrypsin - (Trp, Tyr, Phe, Leu, others) - Pro - 
Thermolysin - (many) - (hydrophobic) - Pro - 
Staphylococcus aweus protease - (Glu, Asp, Gin, Asn) - Pro - 
Aminopeptidase M” (= microsomal alanyl (neutral) - Pro - 
aminopeptidase) Pro - (many) - 
Leucyl aminopeptidase (hydrophobic) - Pro - 
Carboxypeptidases A and B - (many) - Pro 
Cathepsin B2 (= lysosomal carboxypeptidase B) - Pro - many 
Angiotensin converting enzyme (= peptidyl 
dipeptidase A) - (many) - Pro - (many) 
Data compiled from [l-3]. Reports about a different specificity of aminopeptidase M seem to be caused 
by contaminations with other exopeptidases, e.g. dipeptidyl peptidase IV [4] 
the maturation. Fig. 1 illustrates the stability of X- The substance P precursor is not cleaved behind 
Pro- bonds in the precursors of some regulatory the dibasic sequence -Arg-Arg-Pro- because a pro- 
peptides to the processing proteases (further ex- line residue follows. Instead, the cleavage occurs 
amples [9]). between the two basic residues Arg-57 and Arg-58 
Table 2 
Proline specific mammalian endo- and exopeptidases 
Enzyme Requirements of the cleaved peptides 
Cleavage Other Residues Chain length 
site 
. = Pro 
residues 
accepted 
at 0 
accepted (no. of 
at 0 residues) 
M, (x 10-3) Inhibitors PH Locali- 
optimum zation 
Native Subunit 
Prolyl endopeptidase 
Prolyl amino- 
peptidase 
Aminopeptidase P 
Dipeptidyl pepti- 
dase II 
Dipeptidyl peptidase 
IV 
Lysosomal prolyl 
carboxypeptidase 
Carboxypeptidase P 
Prolinase 
Prolidase 
& 
0-k 
CA- 
& 
++l__ 
40 
--dc 
dc 
CA 
_ #Pro 
_ hydrophobic 
HYP f Pro 
Ala any 
Ala, Hyp #Pro#Hyp 
_ #Pro, 
hydrophobic 
Ala, Gly #Pro 
HYP any 
HYP #Pro 
4-17 70” 
2-4 300” 
3-9 
3-11 lloa 
3-200 220b 
23 210c 
2-7 240’ 
2 300’ 
2 108’ 
74a 
W 
Dip-F 
EDTA 
1, IO-phen- 
anthroline 
53” Dip-F, cations 
120b Dip-F, 
bacitracin 
2sc 
54’ 
Dip-F 
EDTA,Cd’+- 
activated 
EDTA, mer- 
curibenzoate 
7.5 
8.1 
7.8 
5.5 
8.0 
5.2 
7.8 
8.7 
7.5 
S(M) 
S 
M 
S(M) 
The data are compiled from [2] and from work in own laboratory; for action on regulatory peptides see text. S, soluble; M, membrane- 
bound; molecular data for the rat brain enzymesa, rat kidney enzymesb and pig kidney enzymes’; @, any unprotected amino acid; 
Dip-F, diisopropyl fluorophosphate; all peptidases sensitive to chelating agents and carboxypeptidase P are activated by Mn2+ 
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PROCESSED SEQUENCE MATURE PEPTIDE (Ref.1 
July 1988 
Ala - Arg l ____- . . . Arg - Pro - Lys - Pro... Substance P [ 11 1 
_____ . LYS - Lys + Q-IA,, - Pro - Val .,. CLIP (121 
. . . Arg - LYS + _____ a- Arg - Pro - Tyr .._ h 
4 
Ah - Gin - Gly -____ . Ala - Pro - Leu . . h 
4 
. . . Asn- Ser --___ Ala - Pro - Thr . . h 
4 
. . . His - Ser _____ Ala - Pro - Asp . h 
a-Relaxin (13) 
Pancreatic Polypeptide (1.4) 
lnterleukln II II5 1 
a-Chorionicgonodotropin 15) 
Fig. 1. Influence of proline residues on the cleavage of precursors of mgulatory peptides by mammalian processinglproteases (see text). 
Observed cleavage by basic residue-specific endopeptidases P (o = Arg, Lys), signal peptidase w (o = Ala and 
others), and aminopeptidasess . The N-terminal sequences of the mature peptides are boxed. 
of the precursor yielding a N-terminal Arg-Pro-. . . 
sequence in the mature bioactive peptide. This pro- 
teolytic conversion has earlier been classified as 
‘proline-directed (monobasic) arginyl cleavage’ 
[9]. A more complex example is the conversion of 
ACTH to wMSH (= acetylated and amidated 
ACTH l- 13, melanocyte-stimulating hormone) 
and CLIP (= ACTH 18-39, corticotropin-like in- 
termediate lobe peptide) in the pituitary in- 
termediate lobe. These bioactive fragments are 
linked by four basic amino acid residues. As con- 
cluded from the occurrence of intermediates [12], 
the endopeptidase initially cleaves ACTH( l-39) at 
the Lys-16-Arg-17 bond. By removal of one 
arginine residue, ACTH(17-39) is then processed 
to CLIP by the action of an aminopeptidase. 
However, the Arg-18 residue is stable to further 
aminopeptidase sequestration, because a proline 
residue follows. The same mechanism should oc- 
cur in the processing of the human relaxin a-chain 
precursor. As concluded from these data, basic 
residue-specific endopeptidases and aminopep- 
tidases fail to cleave -Arg-Pro- sequences in the 
maturation of peptide precursors. This may ex- 
plain the generation of the non-processed sequence 
-Lys-Pro-Arg-Arg-Pro- in mature neurotensin. 
Also the carboxypeptidase B-like enzyme cannot 
readily remove Arg from -Pro-Arg peptide 
fragments [9]. 
The last residue of the signal (pre-) sequence has 
been found to be either Ala, Ser, Gly, Cys, Thr or 
Gln [5,6]. From the examples in fig.1 it appears 
that the removal of the pre-sequences may also be 
influenced by proline residues. In these examples 
all Ala-Pro- sequences are resistant to the signal 
peptidase, and instead, cleavage occurs after Ser or 
Gly which, of course, are also possible cleaving 
sites. Nevertheless, a list of 90 cleavage sites for 
signal peptides gives no example of X-Pro 
hydrolysis [5]. 
In conclusion, the proteases involved in the in- 
tracellular precursor processing of bioactive pep- 
tides normally are unable to cleave X-Pro- bonds. 
However, especially in invertebrates and lower 
vertebrates processing enzymes with substrate 
specificities to overcome this restriction must exist. 
The pro-sequence of honey bee promellitin consists 
of six X-Pro and five X-Ala repetitive dipeptidyl 
residues [16] which should be removed by the se- 
quential action of a dipeptidyl peptidase of this 
specificity to yield the mature mellitin. The pro- 
sequence of the antifreeze protein from the winter 
flounder contains four X-Pro and seven X-Ala 
repetitive sequences [17], but in this case the pro- 
cessing to the mature peptide occurs in serum [ 181. 
Further investigations are required to clarify 
whether the stepwise cleavage of dipeptides in- 
cluding X-Pro- sequences [19] is a particular 
mechanism for the intracellular maturation of pro- 
peptides also in mammals. 
253 
Volume 234, number 2 FEBS LETTERS July 1988 
3. PROLINE-SELECTIVE PROTEASES IN 
THE DEGRADATION OF MATURE 
PEPTIDES 
The occurrence of proline-selective proteases, 
which cleave peptide bonds resistant o most other 
proteases, suggests that these specialized enzymes 
could play a key role in the final degradation of 
mature peptide hormones or neuropeptides. Beside 
prolyl endopeptidase, the proline-selective dipep- 
tidy1 peptidases are the most attractive candidates 
for such a function since several bioactive peptides 
start with N-terminal X-Pro- sequences as dis- 
cussed above. Like N-terminal cyclisation to 
pyroglutamic acid, acetylation or C-terminal 
amidation, these sequences with a penultimate pro- 
line could be regarded as being protected against 
the degradation of bioactive peptides by non- 
specialized exopeptidases. 
Indeed, human dipeptidyl peptidase IV (DPP’ 
IV, EC 3.4.14.5) liberates X-Pro-dipeptides with 
high activity from several regulatory peptides of 
various chain lengths [20,21]: e.g. from His-Pro- 
NH2 (thyroliberin-fragment generated by pyroglu- 
taminase, of which the metabolite His-Pro 1221 or 
the non-enzymatic formed cyclo(His-Pro) may be 
bioactive), &casomorphin (opioid peptide from 
milk, Tyr-Pro-Phe-Pro-Gly-Pro-Be), substance P 
(Arg-Pro-Lys-Pro-Gln.. . , Mr 1348), pancreatic 
polypeptide (Ala-Pro-Leu.. . , M, 4240), prolactin 
(Thr-Pro-Val.. . , A4, 24000) or human chorionic 
gonadotropin (a-chain Ala-Pro-Asp.. . , M, 
48000). Only peptides with proline in the third 
position, e.g. bradykinin (Arg-Pro-Pro.. .), or 
glycosylation here, e.g. interleukin II (Ala-Pro- 
Thr(CH0). . .) or ai-microglobulin (Gly-Pro-Val- 
Pro-Thr-(CHO). . .) are protected against DPP IV 
attack [21]. Since DPP IV is found in high concen- 
trations at the vascular surface of the capillary en- 
dothelium [23] and the kidney brush border [2], 
circulating peptide hormones of such structure 
should be rapidly sequestered by this enzyme when 
entering the blood stream and/or during renal 
passage. Though no direct experiments, e.g. by use 
of specific DPP IV inhibitors, have yet been under- 
taken, some findings are consistent with this 
hypothesis. Sequence data for the a-subunit of 
chorionic gonadotropin [24], follicle-stimulating 
hormone 1251, luteinizing hormone [26] or thyroid- 
stimulating hormone [27] exhibit a heterogeneity 
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of the N-terminus with and without the X-Pro- se- 
quence. Since this heterogeneity does not result 
from intracellular processing [28], the action of 
DPP IV on the circulating hormones may be 
responsible for it. However, with the exception of 
substance P [29] and possibly His-Pro-NH2 [22] 
the loss of the terminal dipeptidyl sequences does 
not decisively inactivate these peptides. Rather, the 
DPP IV action might facilitate the further 
degradation, since the sequestered residue is then 
susceptible to subsequent aminopeptidase attack 
[4]. As for other neuropeptide degrading pro- 
teases, the biological function of DPP IV in brain 
depends on its precise localization. DPP IV is pre- 
sent at the surface of brain capillaries and lep- 
tomeninges [30,31], and has also been detected in 
synaptosomal fractions [22,32]. In the developing 
brain DPP IV is abundant in neuroblasts [30]. The 
sequestration of the N-terminal tetrapeptide Arg- 
Pro-Lys-Pro of substance P in neuronal cell 
cultures [33], which stimulates neurite outgrowth 
[34], shows a possible importance of DPP IV in 
neuronal proliferation. 
A further proline-selective dipeptidyl peptidase, 
DPP II (EC 3.4.14.2), is a lysosomal enzyme oc- 
curring in endocrine glands, reproductive organs 
and neurons of the brain [2]. It liberates X-Pro- as 
well as X-Ala-dipeptides only from short peptides 
up to 11 residues long [35], even if followed by a 
further proline. Because of this localization and 
specificity it is suggested that DPP II accomplishes 
the final degradation of fragments from interna- 
lized or over produced regulatory peptides. Se- 
quences involving proline bonds are stable to most 
lysosomal proteases. The dipeptides liberated by 
the action of DPP II (in contrast to tri- and 
oligopeptides) readily cross the lysosomal mem- 
brane, and then are metabolized by the ubiquitous 
cytosolic prolidase (table 2). N-terminal X-Pro- se- 
quences may also be overcome by the sequential 
action of two specialized aminopeptidases, namely 
aminopeptidase P and prolyl aminopeptidase (or 
other aminopeptidases of broader specificity). 
Aminopeptidase P (= microsomal proline amino- 
peptidase, EC 3.4.11.9) is a membrane-bound en- 
zyme with widespread tissue distribution [2,36]. In 
the lung it initiates the degradation of circulating 
bradykinin [37]. This vasoactive peptide is com- 
pletely inactivated during a single passage through 
the rat lung. After liberationof the N-terminal Arg 
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by aminopeptidase P, the resulting octapeptide is 
easily sequestered by combined action of DPP IV 
and aminopeptidase M [37]. Prolyl aminopep- 
tidase (EC 3.4.11.5) has been detected as a 
melanostatin (Pro-Leu-Gly-NHz) degrading en- 
zyme [1,2] in the kidney, It has not been in- 
vestigated whether this enzyme attacks strictly this 
substrate or shows broader aminopeptidase prop- 
erties. 
Prolyl endopeptidase (= post-proline cleaving 
enzyme, post-proline endopeptidase, TRH- 
deamidase, brain-kinase B, endooligopeptidase B, 
EC 3.4.21.26) specifically cleaves the -Pro-X- 
bond (but not -Pro-Pro-) in several neuropeptides: 
oxytocin, vasopressin, gonadoliberin, cu-MSH, 
substance P, neurotensin, thyroliberin, bradykinin 
and angiotensin II [38]. High activities of prolyl 
endopeptidase are found in the brain. It seems to 
be mainly a soluble, probably cytosolic protein, 
and therefore its role in the initial degradation of 
secreted neuropeptides is questionable. The 
specific function(s) of this enzyme may be clarified 
by the use of the selective inhibitors, Z-Pro- 
prolinal [39] or Z-Gly-Pro-diazomethylketone 
[40]. However, a prolyl endopeptidase cleaving the 
Pro( IO)-Tyr( 11) bond of neurotensin has recently 
been purified from rat brain synaptic membranes 
[41]. Further studies of the precise cellular and 
subcellular localization in brain are required to 
evaluate the role of prolyl endopeptidases in 
neuropeptide metabolism or other neuronal 
functions. 
Several mammalian carboxypeptidases are 
restricted in their action by the presence of proline 
in the C-terminal ultimate and/or penultimate 
position (table 1). Proline-specific carboxypep- 
tidases are the lysosomal prolyl carboxypeptidase 
(= angiotensinase C, EC 3.4.16.2) and the 
microsomal prolyl carboxypeptidase ( = carboxy- 
peptidase P, EC 3.4.17) which both liberate the 
terminal hydrophobic amino acids after the penul- 
timate proline. The former enzyme has been con- 
sidered to be important for regulating angiotensin 
levels in kidney [42]; however, its distribution in 
diverse cells such as macrophages, endothelial cells 
and fibroblasts suggests a broader role in in- 
tracellular protein degradation [2]. The kidney 
microsomal prolyl carboxypeptidase may extend 
the high proteolytic activity of the renal brush 
border membrane [43]. To define its role more 
precisely, additional data about its tissue localiza- 
tion and specificity are needed. 
The proline specific dipeptidases, namely pro- 
lidase ( = proline dipeptidase, EC 3.4.13.9) cleav- 
ing X-Pro and prolinase (= prolyl dipeptidase, EC 
3.4.13.8) cleaving Pro-X dipeptides, are cytosolic 
enzymes of widespread tissue distribution [ 1,2]. 
Both are strict dipeptidases, and exhibit a complete 
(prolidase) or high (prolinase) specificity for pro- 
line or hydroxyproline. Pro-X dipeptides may also 
be hydrolysed by dipeptidases of broader specifici- 
ty [l], or by prolyl aminopeptidase [2]. Due to 
their localization, both dipeptidases are considered 
to metabolize proline-containing peptide frag- 
ments produced by lysosomal or other intracellular 
proteases. Inherited prolidase deficiency results in 
a massive urinary excretion of X-Pro dipeptides, 
especially Gly-Pro, and mainly affects collagen 
metabolism with clinical signs of lathyrism [2]. 
This reflects the important role that proline- 
specific proteases also have in the degradation of 
structural proteins, especially collagen and elastin. 
But this is another topic. 
4. PERSPECTIVES 
Due to their unique specificity proline-specific 
proteases have been investigated by several en- 
zymologists. However, the functions of these en- 
zymes are still far from being resolved. Depending 
on their localization, namely extracellular (at cell 
surface) or intracellular (at several sites), proline 
selective proteases may play a role in several pro- 
tein degradative systems. To clarify their role in 
the metabolism of regulatory peptides, future 
studies should be directed to examine their precise 
localization, especially in the brain, and to develop 
further specific inhibitors which could be applied 
to cell cultures or in vivo. 
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